What is cbdMD?
Founded in 2015, cbdMD operates as a prominent manufacturer and distributor of a diverse portfolio of hemp-derived wellness products. The company's extensive catalog includes CBD tinctures, capsules, gummies, topicals, and specialized pet care solutions. By maintaining a rigorous focus on product quality and consumer accessibility, cbdMD has successfully carved out a significant share of the wellness market. Their business model leverages a multi-channel distribution strategy, allowing them to meet the rising demand for high-quality, non-psychoactive cannabinoid products across both retail and direct-to-consumer platforms.
How much funding has cbdMD raised?
cbdMD has raised a total of $18.3M across 2 funding rounds:
Debt
$1M
Stock Offering
$17.3M
Debt (2020): $1M with participation from PPP
Stock Issuance/Offering (2020): $17.3M led by Undisclosed
Key Investors in cbdMD
PPP
Public-Private Partnership
Undisclosed Investors
What's next for cbdMD?
With the recent influx of capital, cbdMD is expected to prioritize the expansion of its retail distribution network and the acceleration of its research and development initiatives. The strategic focus will likely shift toward enhancing brand equity and deepening market penetration in key geographic regions. As the regulatory environment for hemp-derived products continues to stabilize, the company is poised to leverage its strengthened balance sheet to explore potential partnerships and operational efficiencies. This phase of growth is critical for maintaining competitive advantage in an industry characterized by rapid innovation and shifting consumer preferences, ultimately aiming to drive long-term shareholder value through sustained revenue growth and market leadership.
See full cbdMD company page
